相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dietary Lactobacillus reuteri prevent from inflammation mediated apoptosis of liver via improving intestinal microbiota and bile acid metabolism
Zishen Lin et al.
FOOD CHEMISTRY (2023)
Novel therapeutic targets for cholestatic and fatty liver disease
Michael Trauner et al.
GUT (2022)
Carbon-Based Materials in Photodynamic and Photothermal Therapies Applied to Tumor Destruction
Karina J. Lagos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion
Hai Hu et al.
NATURE COMMUNICATIONS (2022)
Pharmacotherapies for Drug-Induced Liver Injury: A Current Literature Review
Meng Li et al.
FRONTIERS IN PHARMACOLOGY (2022)
Recent updates on progressive familial intrahepatic cholestasis types 1, 2 and 3: Outcome and therapeutic strategies
Seema Alam et al.
WORLD JOURNAL OF HEPATOLOGY (2022)
Prevotella copri ameliorates cholestasis and liver fibrosis in primary sclerosing cholangitis by enhancing the FXR signalling pathway
Baorong Jiang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2022)
Hierarchy-Assembled Dual Probiotics System Ameliorates Cholestatic Drug-Induced Liver Injury via Gut-Liver Axis Modulation
Qi-Wen Chen et al.
ADVANCED SCIENCE (2022)
Bile acid metabolism and signaling, the microbiota, and metabolic disease
Jingwei Cai et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Lactobacillus casei YRL577 ameliorates markers of non-alcoholic fatty liver and alters expression of genes within the intestinal bile acid pathway
Zhe Zhang et al.
BRITISH JOURNAL OF NUTRITION (2021)
Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis
Kristoffer Kjaergaard et al.
JOURNAL OF HEPATOLOGY (2021)
The gut microbiome-bile acid axis in hepatocarcinogenesis
Liwei Wu et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Intrahepatic Cholestasis of Pregnancy: Natural History and Current Management
Rebecca Roediger et al.
SEMINARS IN LIVER DISEASE (2021)
Gut microbiome and bile acids in obesity-related diseases
Rumei Li et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Metabolic impact of bile acids in gestation
Hei Man Fan et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2021)
Research progress in the role of gut microbiota and its metabolites in intrahepatic cholestasis of pregnancy
Shuaijun Ren et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2021)
CT Image Features under Reconstruction Algorithm in Analysis of the Effect of Probiotics Combined with Ursodeoxycholic Acid in Treatment of Intrahepatic Cholestasis of Pregnancy
Hongxue Liu et al.
JOURNAL OF HEALTHCARE ENGINEERING (2021)
Distinct clinical phenotypes for Crohn's disease derived from patient surveys
Tianyun Liu et al.
BMC GASTROENTEROLOGY (2021)
Role of Ursodeoxycholic Acid in Treating and Preventing Idiosyncratic Drug-Induced Liver Injury. A Systematic Review
Mercedes Robles-Diaz et al.
FRONTIERS IN PHARMACOLOGY (2021)
Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis
Maria Reich et al.
JOURNAL OF HEPATOLOGY (2021)
Lactobacillus casei Alleviated the Abnormal Increase of Cholestasis-Related Liver Indices During Tuberculosis Treatment: A Post Hoc Analysis of Randomized Controlled Trial
Ke Xiong et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2021)
Newer variants of progressive familial intrahepatic cholestasis
Vignesh Vinayagamoorthy et al.
WORLD JOURNAL OF HEPATOLOGY (2021)
Alterations of the Human Gut Microbiota in Intrahepatic Cholestasis of Pregnancy
Qitao Zhan et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
The pathogenesis, models and therapeutic advances of primary biliary cholangitis
Hao Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents
Sho Hasegawa et al.
DRUGS (2021)
Molecular Pathogenesis of Intrahepatic Cholestasis of Pregnancy
Jianping Xiao et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
TGR5 protects against cholestatic liver disease via suppressing the NF-ΚB pathway and activating the Nrf2/HO-1 pathway
Haojun Yang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
Samantha Sarcognato et al.
PATHOLOGICA (2021)
Intestinal microbiota drives cholestasis-induced specific hepatic gene expression patterns
Oriol Juanola et al.
GUT MICROBES (2021)
Effect of different bile acids on the intestine through enterohepatic circulation based on FXR
Junwei Xiang et al.
GUT MICROBES (2021)
TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload
Valeska Bidault-Jourdainne et al.
JHEP REPORTS (2021)
TGR5-dependent hepatoprotection through the regulation of biliary epithelium barrier function
Gregory Merlen et al.
GUT (2020)
Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice
Yunhuan Liu et al.
HEPATOLOGY (2020)
Clinical Management of Primary Biliary Cholangitis-Strategies and Evolving Trends
Lixia Gao et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)
Diversification of host bile acids by members of the gut microbiota
Jenessa A. Winston et al.
GUT MICROBES (2020)
A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways
Mohammed Nabil Quraishi et al.
JOURNAL OF CROHNS & COLITIS (2020)
Gram-negative Microbiota Blooms in Premature Twins Discordant for Parenteral Nutrition-associated Cholestasis
Suchitra K. Hourigan et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2020)
Primary biliary cholangitis: pathogenesis and therapeutic opportunities
Aliya F. Gulamhusein et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
microRNA: The Impact on Cancer Stemness and Therapeutic Resistance
Xueqiao Jiao et al.
CELLS (2020)
Association of relative brain age with tobacco smoking, alcohol consumption, and genetic variants
Kaida Ning et al.
SCIENTIFIC REPORTS (2020)
The Role of the Intestine in the Pathogenesis of Primary Sclerosing Cholangitis: Evidence and Therapeutic Implications
Gregory Dean et al.
HEPATOLOGY (2020)
Roles of Trained Immunity in the Pathogenesis of Cholangiopathies: A Therapeutic Target
Chao Yan et al.
HEPATOLOGY (2020)
A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis
Kris Kowdley et al.
JOURNAL OF HEPATOLOGY (2020)
Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders
Daniel M. Chopyk et al.
GASTROENTEROLOGY (2020)
Cholestatic Liver Diseases: A Primer for Generalists and Subspecialists
Moira B. Hilscher et al.
MAYO CLINIC PROCEEDINGS (2020)
Gut Microbiota-Bile Acid Crosstalk in Diarrhea-Irritable Bowel Syndrome
Kai Zhan et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Deficiency of TGR5 exacerbates immune-mediated cholestatic hepatic injury by stabilizing the β-catenin destruction complex
Jianhua Rao et al.
INTERNATIONAL IMMUNOLOGY (2020)
Early treatment efficacy of S-adenosylmethionine in patients with intrahepatic cholestasis: A systematic review
Mazen Noureddin et al.
WORLD JOURNAL OF HEPATOLOGY (2020)
Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis
Amandeep K. Dhillon et al.
LIVER INTERNATIONAL (2019)
Incidence and Etiology of Drug-Induced Liver Injury in Mainland China
Tao Shen et al.
GASTROENTEROLOGY (2019)
Management of intrahepatic cholestasis in pregnancy
Kirsten R. Palmer et al.
LANCET (2019)
A glycyl radical enzyme enables hydrogen sulfide production by the human intestinal bacterium Bilophila wadsworthia
Spencer C. Peck et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Pulmonary Oxygen Toxicity in Navy Divers: A Crossover Study Using Exhaled Breath Analysis After a One-Hour Air or Oxygen Dive at Nine Meters of Sea Water
Thijs T. Wingelaar et al.
FRONTIERS IN PHYSIOLOGY (2019)
Mechanisms and in vitro models of drug-induced cholestasis
Eva Gijbels et al.
ARCHIVES OF TOXICOLOGY (2019)
Enhanced Microbial Bile Acid Deconjugation and Impaired Ileal Uptake in Pregnancy Repress Intestinal Regulation of Bile Acid Synthesis
Caroline Ovadia et al.
HEPATOLOGY (2019)
The gut microbial influence on cholestatic liver disease
Martin Kummen et al.
LIVER INTERNATIONAL (2019)
Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials
Hana Koutnikova et al.
BMJ OPEN (2019)
Systematic review of progressive familial intrahepatic cholestasis
Alastair Baker et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2019)
Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses
Sara Vieira-Silva et al.
NATURE MICROBIOLOGY (2019)
Probiotic Lactobacillus rhamnosus GG prevents progesterone metabolite epiallaopregnanolone sulfate-induced hepatic bile acid accumulation and liver injury
Li Ren et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Epidemiology and clinical course of primary biliary cholangitis in the Asia-Pacific region: a systematic review and meta-analysis
Na Zeng et al.
HEPATOLOGY INTERNATIONAL (2019)
Diagnosis and Management of Primary Biliary Cholangitis
Zobair M. Younossi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis
Michael Trauner et al.
HEPATOLOGY (2019)
Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial
Gideon M. Hirschfield et al.
JOURNAL OF HEPATOLOGY (2019)
Analysis of metabolome changes in the bile acid pool in feces and plasma of antibiotic-treated rats
C. Behr et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)
Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis
Nobuhiro Nakamoto et al.
NATURE MICROBIOLOGY (2019)
Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy
Ruqi Tang et al.
GUT (2018)
In vitro prediction of drug-induced cholestatic liver injury: a challenge for the toxicologist
Mathieu Vinken
ARCHIVES OF TOXICOLOGY (2018)
Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review
Fabio Tonin et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2018)
Bile acid receptors in the biliary tree: TGR5 in physiology and disease
Kathleen Deutschmann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Importance of microbial defence systems to bile salts and mechanisms of serum cholesterol reduction
Sarka Horackova et al.
BIOTECHNOLOGY ADVANCES (2018)
Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems
M. Leonor Fernandez-Murga et al.
FOOD AND CHEMICAL TOXICOLOGY (2018)
Early assessment of safety and efficacy of tropifexor, a potent non bile-acid FXR agonist, in patients with primary biliary cholangitis: An interim analysis of an ongoing phase 2 study
C. Schramm et al.
JOURNAL OF HEPATOLOGY (2018)
Primary sclerosing cholangitis
Jessica K. Dyson et al.
LANCET (2018)
Novel and emerging therapies for cholestatic liver diseases
Jordan Goldstein et al.
LIVER INTERNATIONAL (2018)
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
C. Corpechot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Intrahepatic Cholestasis of Pregnancy: A Review of Diagnosis and Management
Amber M. Wood et al.
OBSTETRICAL & GYNECOLOGICAL SURVEY (2018)
Macrophage-derived IL-1β/NF-κB signaling mediates parenteral nutrition-associated cholestasis
Karim C. El Kasmi et al.
NATURE COMMUNICATIONS (2018)
The gut-liver axis in hepatocarcinoma: a focus on the nuclear receptor FXR and the enterokine FGF19
Marilidia Piglionica et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
The role of ABC transporters' gene polymorphism in the etiology of intrahepatic cholestasis of pregnancy
Krzysztof Piatek et al.
GINEKOLOGIA POLSKA (2018)
ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum
Matthias Christian Reichert et al.
SEMINARS IN LIVER DISEASE (2018)
Role of TGR5 (GPBAR1) in Liver Disease
Verena Keitel et al.
SEMINARS IN LIVER DISEASE (2018)
Alterations of Gut Microbiota in Cholestatic Infants and Their Correlation With Hepatic Function
Cheng Guol et al.
FRONTIERS IN MICROBIOLOGY (2018)
Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment
Mithat Gunaydin et al.
HEPATIC MEDICINE-EVIDENCE AND RESEARCH (2018)
Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome
Maren H. Harms et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Molecular Magnetic Resonance Imaging Accurately Measures the Antifibrotic Effect of EDP-305 a Novel Farnesoid X Receptor Agonist
Derek J. Erstad et al.
HEPATOLOGY COMMUNICATIONS (2018)
Interaction of gut microbiota with bile acid metabolism and its influence on disease states
Christopher Staley et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2017)
The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls
Martin Kummen et al.
GUT (2017)
Microbiota-induced obesity requires farnesoid X receptor
Ava Parseus et al.
GUT (2017)
Intrahepatic cholestasis of pregnancy. Rare but important
A. E. Kremer et al.
HAUTARZT (2017)
Primary sclerosing cholangitis - a comprehensive review
Tom H. Karlsen et al.
JOURNAL OF HEPATOLOGY (2017)
Comprehensive evaluation of the bactericidal activities of free bile acids in the large intestine of humans and rodents
Masamichi Watanabe et al.
JOURNAL OF LIPID RESEARCH (2017)
Management of cholestatic disease in 2017
Elsemieke de Vries et al.
LIVER INTERNATIONAL (2017)
Interactions between gut bacteria and bile in health and disease
Sarah L. Long et al.
MOLECULAR ASPECTS OF MEDICINE (2017)
Pathogenesis and clinical spectrum of primary sclerosing cholangitis
Neelam G. Gidwaney et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Modulating bile acid pathways and TGR5 receptors for treating liver and GI diseases
Harmeet Malhi et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases
You Li et al.
AUTOIMMUNITY REVIEWS (2017)
Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation
T. Visseren et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2017)
Bile Acid Uptake Transporters as Targets for Therapy
Davor Slijepcevic et al.
DIGESTIVE DISEASES (2017)
Engineered Fibroblast Growth Factor 19 Reduces Liver Injury and Resolves Sclerosing Cholangitis in Mdr2-Deficient Mice
Mei Zhou et al.
HEPATOLOGY (2016)
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Annika Wahlstrom et al.
CELL METABOLISM (2016)
Intrahepatic cholestasis of pregnancy: Recent advances
Caroline Ovadia et al.
CLINICS IN DERMATOLOGY (2016)
Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment
Giuseppe Orso et al.
DIGESTIVE AND LIVER DISEASE (2016)
Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD
Joao Sabino et al.
GUT (2016)
Primary Sclerosing Cholangitis
Konstantinos N. Lazaridis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota
Ming-liang Chen et al.
MBIO (2016)
Activation of necroptosis in human and experimental cholestasis
Marta B. Afonso et al.
CELL DEATH & DISEASE (2016)
The pathophysiology of intrahepatic cholestasis of pregnancy
Peter H. Dixon et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2016)
Rho-kinase/myosin light chain kinase pathway plays a key role in the impairment of bile canaliculi dynamics induced by cholestatic drugs
Ahmad Sharanek et al.
SCIENTIFIC REPORTS (2016)
Primary Biliary Cholangitis: Disease Pathogenesis and Implications for Established and Novel Therapeutics
Amitkumar Patel et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2016)
Interactions between Diet, Bile Acid Metabolism, Gut Microbiota, and Inflammatory Bowel Diseases
Suzanne Devkota et al.
DIGESTIVE DISEASES (2015)
Negative feedback regulation of bile acid metabolism: Impact on liver metabolism and diseases
John Y. L. Chiang
HEPATOLOGY (2015)
New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond
Ulrich Beuers et al.
JOURNAL OF HEPATOLOGY (2015)
Cross-talk between bile acids and intestinal microbiota in host metabolism and health
Yang-fan Nie et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2015)
TGR5 and Immunometabolism: Insights from Physiology and Pharmacology
Alessia Perino et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
TGR5: Pathogenetic Role and/or Therapeutic Target in Fibrosing Cholangitis?
Verena Keitel et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2015)
Probiotics and the BSH-related cholesterol lowering mechanism: a Jekyll and Hyde scenario
Sy-Bing Choi et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2015)
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Changtao Jiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
The Mucosa-associated Microbiota of PSC Patients is Characterized by Low Diversity and Low Abundance of Uncultured Clostridiales II
Noortje G. Rossen et al.
JOURNAL OF CROHNS & COLITIS (2015)
Changes in bile acids, FGF-19 and sterol absorption in response to bile salt hydrolase active L. reuteri NCIMB 30242
Christopher J. Martoni et al.
GUT MICROBES (2015)
Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19
Mei Zhou et al.
CANCER RESEARCH (2014)
The bile acid TGR5 membrane receptor: From basic research to clinical application
Henri Duboc et al.
DIGESTIVE AND LIVER DISEASE (2014)
Probiotic VSL#3 Reduces Liver Disease Severity and Hospitalization in Patients With Cirrhosis: A Randomized, Controlled Trial
Radha K. Dhiman et al.
GASTROENTEROLOGY (2014)
Peroxisome Proliferator-Activated Receptor α Activates Human Multidrug Resistance Transporter 3/ATP-Binding Cassette Protein Subfamily B4 Transcription and Increases Rat Biliary Phosphatidylcholine Secretion
Nisanne S. Ghonem et al.
HEPATOLOGY (2014)
Decreasing Mitochondrial Fission Prevents Cholestatic Liver Injury
Tianzheng Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Incidence, Prevention, and Treatment of Parenteral Nutrition-Associated Cholestasis and Intestinal Failure-Associated Liver Disease in Infants and Children: A Systematic Review
Giuseppe Lauriti et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2014)
Intrahepatic Cholestasis of Pregnancy
Catherine Williamson et al.
OBSTETRICS AND GYNECOLOGY (2014)
Bile salts act as effective protein-unfolding agents and instigators of disulfide stress in vivo
Claudia M. Cremers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
A nontumorigenic variant of FGF19 treats cholestatic liver diseases
Jian Luo et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
The Liver May Act as a Firewall Mediating Mutualism Between the Host and Its Gut Commensal Microbiota
Maria L. Balmer et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Microbiota Modification with Probiotics Induces Hepatic Bile Acid Synthesis via Downregulation of the Fxr-Fgf15 Axis in Mice
Chiara Degirolamo et al.
CELL REPORTS (2014)
HMGB1 in severe soft tissue infections caused by Streptococcus pyogenes
Linda Johansson et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2014)
Total parenteral nutrition-associated cholestasis and risk factors in preterm infants
Turki M. Alkharfy et al.
SAUDI JOURNAL OF GASTROENTEROLOGY (2014)
Progressive Familial Intrahepatic Cholestasis
Anshu Srivastava
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2014)
Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
Sama I. Sayin et al.
CELL METABOLISM (2013)
Drug-Induced Cholestasis
Kalyan Ram Bhamidimarri et al.
CLINICS IN LIVER DISEASE (2013)
Nuclear Receptors as Drug Targets in Cholestatic Liver Diseases
Emina Halilbasic et al.
CLINICS IN LIVER DISEASE (2013)
Intrahepatic cholestasis in common chronic liver diseases
Christoph Juengst et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2013)
Population-Based Epidemiology, Malignancy Risk, and Outcome of Primary Sclerosing Cholangitis
Kirsten Boonstra et al.
HEPATOLOGY (2013)
Geoepidemiology of primary sclerosing cholangitis: A critical review
Atsushi Tanaka et al.
JOURNAL OF AUTOIMMUNITY (2013)
Modulation of the fecal bile acid profile by gut microbiota in cirrhosis
Genta Kakiyama et al.
JOURNAL OF HEPATOLOGY (2013)
Contribution of the 7β-hydroxysteroid dehydrogenase from Ruminococcus gnavus N53 to ursodeoxycholic acid formation in the human colon
Ja-Young Lee et al.
JOURNAL OF LIPID RESEARCH (2013)
Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity
Fei Li et al.
NATURE COMMUNICATIONS (2013)
Treatment of Parenteral Nutrition-Associated Liver Disease: The Role of Lipid Emulsions
Prathima Nandivada et al.
ADVANCES IN NUTRITION (2013)
Probiotics-Interactions with Bile Acids and Impact on Cholesterol Metabolism
Nebojsa Pavlovic et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2012)
Selective Activation of Nuclear Bile Acid Receptor FXR in the Intestine Protects Mice Against Cholestasis
Salvatore Modica et al.
GASTROENTEROLOGY (2012)
S-ADENOSYLMETHIONINE IN LIVER HEALTH, INJURY, AND CANCER
Shelly C. Lu et al.
PHYSIOLOGICAL REVIEWS (2012)
BSEP inhibition - In vitro screens to assess cholestatic potential of drugs
Emese Kis et al.
TOXICOLOGY IN VITRO (2012)
Progressive familial intrahepatic cholestasis
Emmanuel Jacquemin
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2012)
Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid
C. Levy et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Pathogenesis of primary sclerosing cholangitis
Marion J. Pollheimer et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2011)
Bile Acid Is a Host Factor That Regulates the Composition of the Cecal Microbiota in Rats
K. B. M. Saiful Islam et al.
GASTROENTEROLOGY (2011)
Dual Farnesoid X Receptor/TGR5 Agonist INT-767 Reduces Liver Injury in the Mdr2-/- (Abcb4-/-) Mouse Cholangiopathy Model by Promoting Biliary HCO3- Output
Anna Baghdasaryan et al.
HEPATOLOGY (2011)
Drug-Induced Cholestasis
Manmeet S. Padda et al.
HEPATOLOGY (2011)
Differences in presentation and progression between severe FIC1 and BSEP deficiencies
Ludmila Pawlikowska et al.
JOURNAL OF HEPATOLOGY (2010)
Guidance for Substantiating the Evidence for Beneficial Effects of Probiotics: Current Status and Recommendations for Future Research
Ger T. Rijkers et al.
JOURNAL OF NUTRITION (2010)
A human gut microbial gene catalogue established by metagenomic sequencing
Junjie Qin et al.
NATURE (2010)
Nuclear receptors as therapeutic targets in cholestatic liver diseases
Gernot Zollner et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Bile Salts Control the Antimicrobial Peptide Cathelicidin Through Nuclear Receptors in the Human Biliary Epithelium
Emilie D'Aldebert et al.
GASTROENTEROLOGY (2009)
High Expression of the Bile Salt-Homeostatic Hormone Fibroblast Growth Factor 19 in the Liver of Patients with Extrahepatic Cholestasis
Frank G. Schaap et al.
HEPATOLOGY (2009)
EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
Ulrich Beuers et al.
JOURNAL OF HEPATOLOGY (2009)
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Philippe Lefebvre et al.
PHYSIOLOGICAL REVIEWS (2009)
β-Klotho and FGF-15/19 inhibit the apical sodium-dependent bile acid transporter in enterocytes and cholangiocytes
Jyoti Sinha et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells
Fabian Arenas et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Etiopathogenesis of primary sclerosing cholangitis
Roger Chapman et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
ATP8B1 requires an accessory protein for endoplasmic reticulum exit and plasma membrane lipid flippase activity
Coen C. Paulusma et al.
HEPATOLOGY (2008)
Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
Insook Kim et al.
JOURNAL OF LIPID RESEARCH (2007)
The burden of large and small duct primary sclerosing cholangitis in adults and children: A population-based analysis
Gilaad G. Kaplan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Mechanisms of Disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis
Beth A. Carter et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2007)
Hepatobiliary transporters and drug-induced cholestasis
Christiane Pauli-Magnus et al.
HEPATOLOGY (2006)
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
T Inagaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria
P Kurdi et al.
JOURNAL OF BACTERIOLOGY (2006)
Intestinal failure-associated liver disease: What do we know today?
DA Kelly
GASTROENTEROLOGY (2006)
Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy
Tomas Binder et al.
JOURNAL OF PERINATAL MEDICINE (2006)
Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis
Ulrich Beuers
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2006)
Outcome and prognostic markers in severe drug-induced liver disease
E Björnsson et al.
HEPATOLOGY (2005)
Progressive familial intrahepatic cholestasis: Genetic disorders of biliary transporters
MJ Harris et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis
S Fiorucci et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis
K Dilger et al.
HEPATOLOGY (2005)
The interaction between bacteria and bile
M Begley et al.
FEMS MICROBIOLOGY REVIEWS (2005)
Effects of lipid administration on liver apoptotic signals in a mouse model of total parenteral nutrition (TPN)
Y Tazuke et al.
PEDIATRIC SURGERY INTERNATIONAL (2004)
A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of gestational cholestasis
N Roncaglia et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2004)
Enterohepatic bile salt transporters in normal physiology and liver disease
GA Kullak-Ublick et al.
GASTROENTEROLOGY (2004)
Hepatic P-glycoprotein changes with total parenteral nutrition administration
Y Tazuke et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2004)
Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis
JA Holt et al.
GENES & DEVELOPMENT (2003)
Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited
G Paumgartner et al.
HEPATOLOGY (2002)
6α-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity
R Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-α-mediated downregulation of cholesterol 7α-hydroxylase and sterol 27-hydroxylase expression
SM Post et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Induction of IκBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-α activators
P Delerive et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
